Disse Jennifer, Vitale Nicolas, Bader Marie-France, Gerke Volker
Institute of Medical Biochemistry, Centre for Molecular Biology of Inflammation, University of Münster, Münster, Germany.
Blood. 2009 Jan 22;113(4):973-80. doi: 10.1182/blood-2008-06-165282. Epub 2008 Oct 22.
Endothelial cells regulate thrombosis, hemostasis, and inflammatory responses by supplying the vasculature with several factors that include procoagulant von Willebrand factor (VWF) and fibrinolytic tissue-type plasminogen activator (tPA). Both proteins can be secreted in a Ca(2+)-regulated manner after endothelial activation but exhibit opposing physiologic effects. In search for factors that could modulate endothelial responses by selectively affecting the secretion of procoagulant or anticoagulant proteins, we identify here phospholipase D1 (PLD1) as a specific regulator of VWF secretion. PLD1 is translocated to the plasma membrane upon stimulation of endothelial secretion, and this process correlates with the generation of phosphatidic acid (PA) in the plasma membrane. Histamine-evoked secretion of VWF, but not tPA, is inhibited by blocking PLD-mediated production of PA, and this effect can be attributed to PLD1 and not PLD2. Thus, different mechanisms appear to control the agonist-induced secretion of VWF and tPA, with only the former requiring PLD1.
内皮细胞通过向脉管系统提供多种因子来调节血栓形成、止血和炎症反应,这些因子包括促凝血的血管性血友病因子(VWF)和纤溶的组织型纤溶酶原激活物(tPA)。在内皮细胞激活后,这两种蛋白质都可以以Ca(2+)调节的方式分泌,但表现出相反的生理效应。为了寻找能够通过选择性影响促凝血或抗凝血蛋白的分泌来调节内皮细胞反应的因子,我们在此确定磷脂酶D1(PLD1)是VWF分泌的特异性调节因子。在内皮细胞分泌受到刺激时,PLD1会转位到质膜,这一过程与质膜中磷脂酸(PA)的生成相关。通过阻断PLD介导的PA生成可抑制组胺诱发的VWF分泌,但不影响tPA分泌,且这种效应可归因于PLD1而非PLD2。因此,不同的机制似乎控制着激动剂诱导的VWF和tPA分泌,只有前者需要PLD1。